Millrace Asset Group’s Enzo Biochem, Inc. ENZ Stock Holding History

Millrace Asset Group’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-170,144	Closed	-$1.39M	–	76
2017 Q4	$1.39M	Buy	170,144 +50,906	+43%	+$486K	1.33%	39
2017 Q3	$1.25M	Buy	119,238 +3,360	+3%	+$37.3K	1.17%	46
2017 Q2	$1.28M	Sell	115,878 -34,122	-23%	-$318K	1.21%	48
2017 Q1	$1.26M	Buy	+150,000	New	+$1.06M	1.28%	49
2016 Q3	–	Sell	-131,956	Closed	-$788K	–	67
2016 Q2	$788K	Sell	131,956 -293,806	-69%	-$1.63M	1.28%	38
2016 Q1	$1.94M	Sell	425,762 -101,512	-19%	-$452K	2.67%	13
2015 Q4	$2.37M	Sell	527,274 -132,237	-20%	-$558K	2.48%	11
2015 Q3	$2.09M	Buy	659,511 +153,928	+30%	+$467K	2.25%	14
2015 Q2	$1.53M	Buy	+505,583	New	+$1.42M	1.6%	31

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Millrace Asset Group's ENZ Position: Q1 2018 in Review

Millrace Asset Group sold out of Enzo Biochem, Inc. (ENZ) in Q1 2018, closing a stake of 170,144 shares — an estimated $1.39M sold.

Millrace Asset Group first reported a position in ENZ in Q2 2015 and held it in 9 quarters. The position peaked at $2.37M in Q4 2015. 107 funds tracked by Wall St. Rank hold ENZ as of Q1 2018.

Millrace Asset Group reported no remaining Enzo Biochem, Inc. position as of Q1 2018 after selling out during the quarter.
Millrace Asset Group sold 170,144 Enzo Biochem, Inc. shares in Q1 2018, an estimated $1.39M.
Millrace Asset Group first reported a position in Enzo Biochem, Inc. in Q2 2015 and held it in 9 quarters.
Millrace Asset Group's Enzo Biochem, Inc. position peaked at $2.37M in Q4 2015.
107 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2018.

Based on Millrace Asset Group's 13F filing for Q1 2018, filed 15 May 2018.